Delivery Order SPE2DB20D2104-SPE2DB25FNAHX
- Not listed
- The Defense Logistics Agency awarded a $12,330.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector pharmaceutical product, with a completion date of August 19, 2025. This non-set-aside contract was awarded competitively on July 29, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a $6,165.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector pharmaceutical products. The contract is non-set-aside and was competitively awarded with an ultimate completion date of August 14, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transaction under the company's broader federal pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector, with an ultimate completion date of September 3, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters operations as a major pharmaceutical distributor...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $12,330.68 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector units. The contract, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed-price procurement executed without set-aside provisions, indicating open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfills this order as part of its extensive federal...
- The Defense Logistics Agency awarded a delivery order valued at $12,330.68 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector pharmaceutical product. This competitively awarded, firm fixed-price contract is scheduled for completion by September 15, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $18,147.78 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 4, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/mL auto-injector on July 21, 2025, with completion scheduled for August 11, 2025. This is a firm fixed price, non-set-aside contract utilizing competitively awarded pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,330.68 for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order on August 15, 2025, valued at $12,330.68 for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, non-set-aside delivery order with a completion deadline of September 8, 2025, and represents a child contract under AmerisourceBergen's larger federal contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injectors. This competitively awarded, non-set-aside contract was finalized on July 31, 2025, with an ultimate completion date of August 21, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract utilizes firm fixed...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNAHXDelivery Order
The Defense Logistics Agency awarded a $12,330.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector supplies, with a completion date of October 3, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor for pharmaceutical products supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The broader IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of specialty medications, brand-name and generic drugs, and medical supplies to military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in fulfilling diverse pharmaceutical requirements through competitive awards with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 9/12/25 |